Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Welcome aboard, Meghan! Gonna be a fun ride with Jushi!
Oh yes, I love it, awesome news. What's not to love about Jushi!!
Great news today! And what a way to kick off the new "Dedicated EV Charging Solutions Division"!!!
Today's news:
https://www.accesswire.com/619847/Solar-Integrated-Roofing-Signs-Agreement-with-Applicant-of-500000000-USTDA-Grant-Solectrac-Inc-to-Supply-Solar-Panels-and-Related-Equipment-and-Installation
Solar Integrated Roofing Signs Agreement with Applicant of $500,000,000 USTDA Grant, Solectrac, Inc., to Supply Solar Panels and Related Equipment and Installation
Tuesday, December 8, 2020 5:30 AM
Topic: Company Update
Agreement includes supplying new and existing Solectrac clients and grant projects
Last week's news:
https://www.accesswire.com/619070/Solar-Integrated-Roofing-Announces-Launch-of-Dedicated-EV-Charging-Solutions-Division
Solar Integrated Roofing Announces Launch of Dedicated EV Charging Solutions Division
Wednesday, December 2, 2020 5:30 AM
Topic: Company Update
Company to Cross-Sell into Existing Pipeline of Solar & Battery Backup Customers; Exploring Potential Acquisitions of Companies in Electric Vehicle (EV) Charging Vertical
Okay, yeah. I guess I meant that, since the stock trades native on the CSE, there could be a mistake the way it was stated, or the writer was indicating "the stock" is Canadian-based, rather than "the company."
Yeah. That's called "stealth accumulation." Some are loading JUSHF heavily. Not unlike me, lol, though I'm not one of them loading $2M in a single day, as I've seen. This is one to hold at least for the next year and a half (imo) during initial price adjustment for PE ratio of comparable tickers. You can use it like an ATM and flip around if you choose, but good chance won't get back in at any lower price as it just continues to climb.
Trades on the Canadian Securities Exchange. Also note the 5th character "F" in JUSHF.
I agree with you on all points. I sure don't expect that it would ever come to a 1:300 reverse, and I am damn sure no one at the company including officers, directors or control shareholders wants to see it come anywhere close to that. In fact, there is already every disincentive possible for that. I've been happy with most everything with the company over several years, and I want them to continue moving this growth machine in the best way they see fit. Now, that's with the conditions of all public commitments that I've listened to (con calls, etc.) and read (PRs, shareholder letters, filings, etc.)... such as no more bucketful stock awards to the founders and controllers, and so on.
So I hope to see all measures pass and to bring on the moves, RXMD!
Yes, as a matter of fact. There are definitely many cases but one is right under your nose, so to speak. I cannot remember the last time AVXL was not on the most read boards list.
Here's a brief summary of the AVXL case example R/S and Nasdaq uplift from OTCQX in 2015 -
The company began planning for it at the beginning of the year (2015) when the pre-split price was in the range of $.15 to $.20. The price grew all year long and by the time of the formal reverse split announcement in early October, was in the range of $1.50 to $2.00 pre-split. The split was 1-for-4 and was effective the very next day after the announcement, when the stock initially dropped to close at about $5.80 ($1.45 pre-split) from the prior day's close of $7.60 ($1.90 pre-split). So it lost about 23% that day. The price then totally recovered after 1 day, and further rallied to a high of $15 just a few days after the Nasdaq listing became effective, about 3 weeks later.
So... correlating where we are today with RXMD, AVXL was in the range of pps= .15 to .20 when plans were initiated for the Nasdaq uplisting. The stock price then ran over 8-9 months to roughly 10x the initial value just prior to the R/S, and then doubled again over the next 20 days, setting up for the first days of trading on Nasdaq.
(refer to the charts below)
(AVXL press releases with final/formal announcement of R/S and also NASDAQ listing follow the charts below)
AVXL did then pull back, as most do after IPO, but settled solidly into the $6 to $8 range, which was still multiples of the original price. The price is STILL around $4 to $6, still trading on Nasdaq, and the company is doing very well. Very well, in fact, for a biotech that STILL has ZERO REVENUE. RXMD has MUCH revenue and is growing rapidly! And can do so more effectively and with access to much higher quality funding when on a national stock exchange!
https://www.anavex.com/anavex-prepares-for-uplisting-to-nasdaq-announces-reverse-stock-split/
https://www.anavex.com/anavex-announces-uplisting-to-nasdaq/
https://www.anavex.com/anavex-commences-trading-on-nasdaq-today-to-ring-fridays-closing-bell/
Chart:
https://www.stockscores.com/chart.asp?TickerSymbol=AVXL&TimeRange=10000&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=BB&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=AccDist&Indicator3=SStoch&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
They said plenty. Everything I have seen and heard from the company tells me this is the right move.
100 million? lol, what's that? I think you're misinformed.
Happy to share, Snup!
Very well and simply put. This entire development, in my opinion, is exactly what we (RXMD long investors) have all strived for. Some (like me) have been around for so long, it can be difficult to see this not get to 4 dollars "organically" before hitting the big boards. But I'm a realist and, in the end, so are the long-timers here that I "know." I think we'll all be on board with giving the approval needed for the board and management to move forward as needed for the purposes outlined. If that doesn't happen, I will say that I have overestimated.
Here are my raw notes. I think I captured the gist of the core presentation and answers:
12/7/20 RXMD Shareholder Conference Call
(Jay) Weisberg -
re December 14 special shareholder meeting to vote
Registration statement... - explanation for why company is requesting approval on a reverse split.
Shareholder questions
Proxy statement, please/suggest that you read carefully and in detail... includes all the info that you require to vote on the measures
Elected confidential treatment for S1 registration filing. Cecile ??? will address this/why... board recommends that you vote yes on each measure. Bob will provide the info necessary to reverse your vote if you already voted and wish to reverse your vote...
Cecile - re question re S1 and process
On Nov 9, requested confidential ... upon filing
Company is required to respond to comments, etc.... this whole thing can be a lengthy process
Bob Bedwell - re questions re stockholders meeting and reasons for voting matters in the proxy etc. - Dec 14, virtually at 10am EST. To discuss a number of important matters that require... Clear Trust before 12/14 if you want to attend the virtual meeting
www.cleartrustonline.com/rxmdmeeting
4 matters:
1. amendment to effect a R/S; approval will not lead to an immediate R/S; will only be done once it is determined that we meet the requirements of a NYSE/NASDAQ listing
2. updates to comply with Delaware corporate law... just details
3. stock incentive plan; 1) to attract appropriate candidates for positions, to include compensation/salary and possibly stock incentives to prospective employees; 2) to current employees to drive performance... to ensure continued perofrmance as a 5-star pharmacy; 3) The 75M shares are "pre-split" shares - meaning they will be affected by any stock split; 4) this is for future employees only - there are no plans inclluded for current executives, etc.
4. finally, to adjourn
So...
1. R/S: is meant to accomplish what we have been describing as our plan for the future... this is to complete an uplist to a national stock exchange. One item is what's referred to as a minimum bid price in order to uplist... which is $3. Our plan is we would like a minimum bid price much higher than that. It's important to have a buffer... our plan is around $5 per share.
1b) the reason for a range of R/S ratios is because we needed to come up with a range of numbers... but we will do the minimum needed in order to accomplish the $5 bid price as our goal.
SO - THAT IS THE MAIN REASON... THAT IS THE STRATEGY.
The reason for the range is that our stock has been trading at, as you know, various prices over the past month. So we need to provide for a range...
It's really up to the exchange itself to determine whether or not we meet the requirements. So we will apply, the best we can do is submit everything and do our best to meet all the requirements.
We need shareholder acceptance of the reverse split, etc.
The problem is that the reason stock declines in our stock price complicate that process a little bit. What are our reasons, etc., for the recent declines... question of Amazon entering into the market in competition... We think it's going to be difficult for Amazon to meet certain logistical rquirements, and it's going to take a while - at least - for Amazon to be able to meet those requirements.
From the standpoint of a R/S and what you're trying to achieve, what is in it for me as a shareholder? A: until now, financing options for the company have been very limited, and certainly many of the (only) options available involve converting loans/debt into shares (toxic debt); uplisting would provide access to an entirely better range of financiing options that are more conventional financing opportunities, etc.
And now... reverting to Cecile:
Cecile:
Now, to address some questions regarding MyApps, etc.
Late November we started working with the MyApps developers... anticipate having complete by end of Q1 2021. And then we can start offering telemedicine visits.
The move from North Miami location we expect to complete before end of 2020 calendar year.
$RXMD Great news! Awesome numbers! They just keep getting better, and look how the 340B keeps growing exponentially. Operating margins improving rapidly too - ready for the big boards!
We're looking very good for this week. The chart is set up perfectly, and Lord knows the fundamentals are amazing with revenue, growth, the pending merger closing, new software rollout and business formation, 7-state expansion of construction licensing to fuel huge step increase in revenue, as well as the future of the drone business that we have as a result of the merger. We'll soon be getting dizzy as the revenue dollars keep rolling up for this more-amazing-everyday holding company that Kent's created!
Great info, thanks for posting Roofus!
Right. I think that's what we're going to get tomorrow in the conference call... sufficient confidence that this is exactly what we should be doing right now, so as to get enough Common Shareholder votes to pass the R/S measure (presumably for uplisting, as seems to be spelled out for us). We'll see how it goes tomorrow afternoon in the call, but I expect that I'll be voting 'for.' Right now I'm leaning 'for' but, though I haven't taken the time to post much over the past few years, I want to be sure to come back after tomorrow's call to cast my "wish" to other shareholders about what I'd like to see.
Well, I answered to your concerns, I'm done with this topic now. If you don't have the legal proxy notice, then I guess you maybe you haven't seen the legal stipulation that COMMON SHAREHOLDERS MUST VOTE 'FOR' the measure for it to pass. GLTY
FYI, just to correlate, here's a snapshot from the proxy notice for the upcoming vote (image below) related to my earlier post.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159955406
I just glossed over and ignored this when I first reviewed the proxy. I guess maybe I should unblock the numbers and take the next call, since they're just doing their job (and I'm paying for it, lol).
No, I'm sorry but YOU are wrong. This easily verified, just look it up in the proxy notice. If you were holding any shares on the record date of October 23, you should have the proxy notice that states explicitly how it works:
Thank you for pointing that out. Also note, Mars was very explicit in her statement last year about this - specifically, that supervoting preferreds shares DON'T COUNT if it ever comes to shareholders to vote on a reverse split.
So where you point out "Common Shareholders must approve," it does seem very clear that, indeed, Common Shareholders MUST approve... or it will not pass. So... the power is in our hands. And Armen & Co will convince us of this (either through recent actions and PRs re S1/uplist or) tomorrow in the conference call, if "we" as a collective majority of common shareholders are not already convinced to vote FOR the measure.
I don't know about you, but I'm feeling pretty damn good about my millions of votes/shares right now. Looking forward to the call tomorrow.
Here's a transcription from that conference call where Shital Mars clearly stated this:
Right, well the statement that you quoted is exactly a 100% true statement:
With Due respect, your point regarding Preferred Shares control being made - this is direct proof of the ONLY conclusion that can be made here... Armen & Co (directors and executive officers of Progressive Care RXMD) are doing EXACTLY what they should be doing, as follows here.
1. Within certain constraints, shareholders have been informed that certain corporate activities toward maximizing shareholder value have been in the works, but that very little can be disclosed publicly until... and now we have seen the PR regarding the S1, in addition to the proposed corporate actions for which there is an upcoming special meeting to vote.
2. Common shareholder votes were not immediate, and so - as you correctly pointed out - the company is properly using a proxy solicitor to engage and include common shareholders in the vote.
3. It seems to be no coincidence that, following less than optimal results from proxy solicitation and calls to Armen from certain shareholders requesting further information/explanation regarding the proposed corporate actions, the PR was published regarding the S1 and a shareholder conference call was arranged.
The ONLY conclusion that can be made is that the company is behaving in a way that is consistent with the best interests of long shareholders... taking further steps to convince us to vote and vote favorably - EVEN THOUGH they may not NEED to, technically.
Maybe it's just not so good for those who are short - whether "technically" short or just short on shares at the moment.
From my perspective, it has always been: "Armen, CONVINCE me." And that's the sentiment I've seen on this board for years from the general retail investing public. So... Armen is doing what he can, to convince us. Simple as that.
$RXMD My sentiments exactly, thanks for sharing. I have a decent position as well, and actually made some timely and hefty additions to my position after the record date (Oct 23):
$ALPP Who missed this?!? Or better yet, who really understands this?!? Other than me, lol!
We may be hearing sometime REAL soon that we've got additional building construction/maintenance contracts of 10's of millions of dollars for 2021 over this year. This is spelled out CLEARLY in the "500% increase in bids totaling over $100M" (note, an increase in bids should presumably result in a proportionate increase in awards and therefore REVENUE). This could EASILY double the entire corporate income or better, alone! This is IN ADDITION to the HUMONGOUS bolster that we shareholders will see from the pending reverse triangular merger with Impossible Aerospace Corp due to close on 12/10 (just one week from today)!!!!
FIRST - yesterday's PR - I wonder how many folks passing by this stock have a clue how HUGE this news is:
https://www.accesswire.com/619150/Excel-Fabrication-an-Alpine-4-Technologies-Ltd-ALPP-Subsidiary-Is-Now-A-Supplier-For-Varco-Pruden-Buildings-Inc-Swelling-Bid-Work-In-Excess-Of-100M
Excel Fabrication, an Alpine 4 Technologies, Ltd. (ALPP) Subsidiary, Is Now A Supplier For Varco Pruden Buildings, Inc., Swelling Bid Work In Excess Of $100M+
Wednesday, December 2, 2020 8:30 AM
In this press release:
Here's what is going on, fyi. CFGN likely has the final tranche of shares from the S1. As soon as CFGN came down to start selling today... a handful of traders came down on the ASK to get under CFGN to flip their shares for a lower price. Smart buyers know this and are taking advantage of discount pricing for the moment, and they are aware that this is the last of the cheap shares while day-flippers are working it. You will see, as this becomes more obvious to more buyers, they will soon be stepping over each other as the price runs higher on demand. It has only just begun. tik
tik
tik
tik tok
$SIRC Luv'in THIS news!!
Just FYI for those new or window shopping here, because I just replied this to someone in a PM -
I'll have to dig and see what revenue was previously - this means what, over 500% increase in whatever previous revenue was, right?!? Assuming same rate of bid awards.
Crazy great news today! Love this -
$ALPP Awesome, Awesome, Awesome!!This shows that CFGN is done selling those 14 million S1 fundraising shares from the July registration. No further dilution to slow down the price movement, we are golden here!!
This makes the float roughly 114M. Very happy to be holding a healthy chunk of it!!!
$ALPP 20% of the float traded today so far, 20M shares at VWAP=.31
We will go up much further.
Of course you’re wrong here. Two wholly owned subsidiaries. DD, it’s simple.
Marked you #1!
$SIRC Nicely done, this is REALLY good to hear “from the horse’s mouth,” though, as well! I recommend to all to listen to the audio directly.
Thanks for taking the time and for sharing, Mercutos!
$ALPP 25% of the float has traded so far today at an average price over .20
...do you think this breaks upward? LOOK OUT ABOVE!!
25.5M shares traded, VWAP=0.2025, $5.56M dollar volume
So having an actual acquisition where both parties do a joint interview about said merger... it’s called informing their investors of things to come.
Great interview with the founder of Impossible Aerospace and Kent Wilson, CEO of ALPP:
Here are the facts on this. Checked with ALPP and they said they have not engaged that firm to market them. It’s obviously about solar which ALPP isn’t involved in. Most likely one of the other companies paid for it and is piggy backing on the success of ALPP’s awareness yesterday.
Not good? Lol, right. ALPP has big news, and investors like myself do appreciate the company's effort to get more eyes.
ALPP has a small float. Anyone wanting a position can simply slap the ask and buy as much as they want.
Good post, Chuck.
$PASOS's to Dollars!